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ABSTRACT  We  examined  the  microtubule-binding  domain  of  the  microtubule-associated 
protein  (MAP), MAP-2, using rabbit  antibodies  that  specifically  bind  to  the  microtubule- 
binding  region ("stub")  and  the  projection  portion  ("arm") of  MAP-2. We  found  that  (a) 
microtubules  decorated with arm antibody look similar to those labeled with whole unfrac- 
tionated MAP antibody, though microtubules are not labeled with stub antibody; (b) incubation 
of depolymerized  microtubule  protein with stub antibody prior to assembly partially inhibits 
the  rate of  microtubule  elongation,  presumably because MAPs that  are  complexed  with 
antibody  cannot  bind  to  microtubules  and  stabilize elongating  polymers; (c)  the  rate of 
appearance  and  amounts  of  36-  and  40-kD  microtubule-binding  peptides  produced  by 
digestion with chymotrypsin are distinct for MAPs associated with microtubules vs. MAPs free 
in solution. The enhanced stability of the 40-kD  peptide when associated with microtubules 
suggests that this domain of the protein  is closely associated with,  or partially buried  in, the 
microtubule  surface; (d) MAP-2 is a slender, elongate molecule as determined by unidirectional 
platinum  shadowing (90 __+ 30 nm), which  is in approximate agreement with previous obser- 
vations. Stub antibody labels MAP-2 in the terminal  one-quarter  of the  extended  protein, 
indicating an intrinsic asymmetry in the molecule. 
Microtubules isolated from brain tissue by cycles of temper- 
ature-dependent assembly and disassembly contain tubulin 
and several microtubule-associated proteins (MAPs) l, includ- 
ing MAP-1  (300 kD), MAP-2 (280 kD), and tau (55-70 kD), 
which co-purify with tubulin and promote microtubule as- 
sembly  and  stabilization  in  vitro (Berkowitz et  al.,  1977; 
Borisy et al.,  1975; Herzog and Weber,  1978; Murphy and 
Borisy, 1975; Sloboda et al.,  1976; Weingarten et al.,  1975). 
MAP-2 comprises more than half of the nontubulin protein 
in microtubules prepared by in vitro assembly. 
By platinum shadowing, thin sectioning, and negative stain- 
ing methods, MAP-2 has been shown to project outward from 
the microtubule wall (Voter and Erickson,  1982; Zingsheim 
et al.,  1979; Amos,  1977;  Dentler et al.,  1975; Kim et al., 
1979; Murphy and Borisy, 1975). Cleavage  of microtubules 
containing MAPs with alpha chymotrypsin produces a  35- 
40-kD microtubule-binding domain which binds to microtu- 
bules and stimulates assembly, as well as a 240-kD projection 
portion which lacks microtubule-binding activity (Vallee and 
Borisy,  1977).  However, the exact size  of the microtubule- 
binding region of MAP-2 and its position relative to tubulin 
t Abbreviations  used  in  this  paper: 
protein; MTP, microtubule  protein. 
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MAP,  microtubule-associated 
subunits in the microtubule wall  have not yet been deter- 
mined. 
MAP-2 has also been shown to be bound to microtubule 
surfaces in a  regular manner, there being a  32-nm periodic 
spacing between adjacent  MAPs on the lateral surfaces of 
microtubules. Amos (1977) proposed that the pattern of  MAP 
attachment is helical and may be related to the helical arrange- 
ment of tubulin subunits in the microtubule wall. However, 
Voter and Erickson (1982),  using platinum shadowing, did 
not observe a regular distribution of MAPs on microtubules, 
and both Sheterline (1978) and Gottlieb and Murphy (1983) 
observed a  100-nm repeat interval using MAP antibody la- 
beling procedures. Therefore, there is not a consistent picture 
regarding the details of the pattern of MAP-2 attachment on 
microtubules. 
In an effort to obtain more detailed information about the 
distribution of MAPs on microtubules and especially about 
the location and size of the microtubule-binding domain of 
MAP-2, we used antibodies specific  to different portions of 
MAP-2. By affinity chromatography of polyclonal rabbit an- 
tibodies to MAP-2, we obtained one fraction that specifically 
labels the 36-40-kD microtubule-binding portion of MAP-2 
("stub") and  another antibody fraction that  recognizes the 
projection portion of  MAP-2 ("arm"). In this paper we present 
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to stub and ann domains of MAP-2. 
MATERIALS AND  METHODS 
Preparation of Cycled Microtubule Protein 
and MAP-2 
Microtubule  protein  was purified from hog brain by two cycles of in vitro 
assembly and disassembly in 0. l M Na-PIPES buffer at pH 6.94 by a modifi- 
cation  of the method of Borisy et al. (1974) as described by Murphy (1982). 
For most experiments,  microtubule  pellets which had been  stored at -80"C 
were thawed,  resuspended  in assembly  buffer  (0.1 M  Na-PIPES,  pH  6.94, 
containing  0.1  mM MgCI and 1.0 mM GTP) and passed through a third cycle 
of temperature-dependent  assembly-disassembly  to  prepare  a  microtubule 
protein  (MTP). Fractions of purified MAP-2 were prepared by heat treatment 
(FeUous et al., 1977) followed by gel filtration chromatography  on 4% agarose. 
Preparation of MAP Arm and MAP Stub 
Affinity Columns 
Hog brain MTP at 3 mg/ml in assembly buffer containing  10% glycerol was 
polymerized with taxol (30 uM), pelleted through 25% sucrose cushions con- 
taining taxol, and resuspended to 3 mg/ml in assembly buffer with taxol. To 
generate  MAP  arm and  stub fragments,  alpha-chymotrypsin  (Worthington 
Biochemical  Corp.,  Freehold,  NJ) was added  (0.1 /~g/1.0 mg MTP,  5  min, 
37"C), the reaction was arrested with 5 mM phenylmethylsulfonyl fluoride, and 
the microtubules were removed by pelleting through 25% sucrose cushions. 
MAP  ARM  AFFINITY  COLUMN:  MAP  "arms" released by treatment 
with chymotrypsin were precipitated with 50% ammonium sulfate, resuspended 
in water, and centrifuged briefly to remove insoluble aggregates. The soluble 
material was fractionated  by gel filtration  chromatography  (BioGel Al5m) to 
isolate  the  large proteolytic  fragments  (140  and  180  kD)  corresponding  to 
"arm" (column buffer: 50 mM imidazole, 50 mM KC1, 10 mM beta-mercap- 
toethanol,  0.5  mM  MgCI, 0.1  mM EDTA,  pH  7.0). To prepare  an affinity 
column for arm-specific antibodies, we selected fractions which excluded intact 
MAP-2  and  smaller  fragments  the  same size as  the  "stub." The  fractions 
containing  "arm" were concentrated  by ammonium sulfate precipitation  and 
then  linked  to cyanogen  bromide-activated  Sepharose by standard  methods 
(Porath,  1974). 
MAP STUB AFFINITY COLUMN:  The microtubule  pellet obtained afier 
chymotryptic digestion was resuspended in assembly buffer with taxol (10 ~,M), 
incubated  at  37"C for 20  min, and  made 0.35 M in  NaCI according  to the 
method  of Vallee (1982) to release MAP stubs  from the  microtubules.  The 
microtubules were pelleted by centrifugation, and the stub-containing supernate 
was dialyzed against ammonium bicarbonate  (pH 7.0), lyophilized, and resus- 
pended in water. This material was loaded on a  12% preparative SDS polyac- 
rylamide gel, electrophoresed,  and lightly stained  (10 min in  1% Coomassie 
blue, then destained in water) to visualize the bands. The zone containing  the 
bands corresponding to 35-40-kD stub fragments was cut out from the gel and 
the stub peptides were eluted by electrophoresis (Stephens, 1975), concentrated 
by dialysis, and attached to cyanogen bromide-activated  Sepharose. 
Preparation of MAP Antibodies 
Rabbits were immunized  with heat-soluble fractions of MAP-2 (Fellous et 
al, 1977; KJm et al., 1979) that were purified by gel filtration chromatography 
and combined  with Bentonite  by the  method of Gallily and Garvey  (1968). 
Antiserum  was examined  for specific antibody  by a solid-phase binding assay 
using the procedure  of Tsu and Herzenberg (1980) as modified by Kiehart  et 
al. (1984). We used polystyrene microtiter  plates and ~251-1abeled protein  A to 
quantitate the amount of  antibody binding. The specificity of  antibody fractions 
was determined  by examining the binding of proteins that were fractionated by 
SDS gel electrophoresis and transferred by electrophoretic blotting onto nitro- 
cellulose sheets by the method of Towbin et al. (1979). Strips labeled with ~251- 
protein A were dried, and autoradiograms  were prepared to identify immuno- 
reactive components. 
Antibodies specific to MAP-2 were purified on an affinity column prepared 
from cyanogen bromide-activated  Sepharose containing  MAP-2 as described 
by Porath  (1974), and eluted by a modification  of the procedure described by 
Bennett and Stenbuck (1979). In earlier work, this antibody has been shown to 
recognize MAP-2 and its proteolytic fragments, but not tubulin or tau (Gottlieb 
and Murphy,  1983). 
To purify antibody  against the arm component of MAP-2, antiserum was 
passed over an affinity column containing stub antigen. The flow-through from 
this column (containing IgG which did not bind stub antigen) was then passed 
over an affinity column containing arm antigen, eluted with 1.0 M acetic acid, 
partially neutralized to pH 4.0 with 1 M Tris, dialyzed against PBS, and stored 
at -80"C until use. This material is referred to as "arm" antibody. 
To purify antibody against the stub component of MAP-2, the flow-through 
fraction  from an arm affinity column (IgG which did  not bind arm antigen) 
was passed over a stub affinity column and eluted  and treated  as described 
above. This preparation  is referred to as "stub" antibody. 
Protein A-Gold Colloid Preparation 
Reduction of gold chloride by sodium borohydride to form the colloid was 
performed  according  to  the  method of Rash  et  al.  (1982).  Protein  A  was 
adsorbed onto the activated colloid by a modification of  the procedure described 
by Horisberger and Rosset (1977). Protein-coated colloid was fractionated  on 
glycerol gradients to obtain particles with an average diameter of 10-20 nm as 
determined by electron microscopy. For antibody labeling experiments, protein 
A-gold colloid was used at a concentration  giving an optical density of  0.33 at 
520 nm. We found by evaluation  of grids containing  decorated microtubules 
that this concentration  gave optimal  labeling of microtubules  relative to the 
background. 
Antibody Labeling of Microtubules 
Microtubule  protein  was polymerized  at 37°C in assembly buffer with  l0 
uM taxol for 15  min and then diluted  to 0.25 mg/ml in pre-warmed  buffer 
containing  1% glutaraldehyde. After 2 min, 3 #l were deposited on a carbon- 
coated grid, treated three  times with 20 mM sodium borohydride  for 4 rain 
each time to inactivate  residual aldehyde groups (Osborn and Weber,  1982), 
rinsed three times with phosphate-buffered saline (PBS) for 3 min each time, 
incubated with MAP-2 antibody (0.1 mg/ml in PBS) for 30 rain, rinsed twice 
with PBS for 3 min each time,  incubated  with protein  A-gold  colloid for 15 
min, rinsed twice again with PBS for 3 rain each time, and negatively stained 
with 1% aqueous uranyl acetate. 
Platinum Shadowing of MAP-2 and MAP-2 Stub 
Antibody Complexes 
MAP-2 prepared  as described above was diluted  to 20 ~g/ml in distilled 
water and 15% glycerol, sprayed onto freshly cleaved mica, and vacuum dried 
at room temperature  using a Polaron  evaporator  for up to 5 h, or until  the 
vacuum was better than 5 x  10  -7 tort (Hall, 1956; Fowler and Erickson, 1979; 
and  Voter  and  Erickson,  1982). The dried  specimens were then shadowed 
unidirectionally  at  a 6* angle. A carbon  coating  deposited  directly over the 
specimen  stabilized the  metal  replicas, which  were then  floated off onto a 
distilled water surface and picked from beneath  with 400 mesh copper grids. 
After the grids were dried  they were examined  in a Zeiss EM  10A electron 
microscope. 
To visualize stub antibody  bound to MAP-2, we incubated  MAP-2 at 130 
zg/ml with stub antibody at 63/~g/ml for 60 min at 37"C (molar ratio of~l:l). 
To overcome  surface tension  effects which  tended  to disrupt  the antigen- 
antibody  complexes, we diluted  this  solution  100-fold in  20%  glycerol and 
water, and sprayed the  mica sheets heavily so that the droplets  coalesced to 
form a thin film of solution over the entire mica sheet. We found this to yield 
a better distribution  of material with greater preservation of antigen-antibody 
complexes than other methods. Samples were vacuum dried and shadowed as 
described above. Random fields of  the electron microscopy grids were examined 
and every antigen-antibody  complex observed was photographed  at a magni- 
fication of 50,000x. 
Turbidimetric Assays of Microtubule Assembly 
Cycled microtubule  protein was cold.-depolymerized, sonicated, and centri- 
fuged at 200,000 g for 2 h at 5°C to remove rings. This high-speed supernate 
was diluted to l mg/ml and incubated for 15 min at 0°C with PBS, preimmune 
IgG, MAP-2 antibody, arm antibody,  or stub antibody  at 0.05 or 0.5 mg/ml. 
The sample was incubated for 45 s in a water-jacketed cuvette to allow complete 
equilibration  to assembly temperature  (30°C). Polymerized, sheared mierotu- 
bules (seeds) were added to a final concentration  of 0.17 mg/ml and turbidity 
changes were recorded at 350 nm. Initial rates of  polymerization obtained from 
the  slopes  of the  recordings  were  corrected  (+10%)  to  account  for  slight 
differences in the amount of seeds added to the cuvettes. 
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Protein Concentration 
SDS slab gels containing 12% acrylamide  were prepared  by the method of 
Laemmli  (1970) with the modification  of  Anker (1970). Gels  were  stained with 
Coomassie Blue and destained as described by Fairbanks  et al. (1971). Protein 
was applied  to gels  in amounts  known  to fall  within the linear range  of  staining 
intensity with Coomassie  Blue (Borisy  et al, 1975). 
Protein concentrations  were determined according  to the method of Brad- 
ford (1976) with bovine serum albumin as a standard. 
RESULTS 
Characterization of Affinity-Purified Antibodies to 
MAP Arm and Stub 
We purified antibodies to the microtubule-binding portion 
(stub) and projection portion (arm) of MAP-2 as described in 
Materials  and  Methods.  The  MAP antibody is specific for 
MAP-2  and  does  not  recognize either  MAP-1  or tau  (not 
shown). The relative specificities of arm and stub antibodies 
were examined by immunoblotting (Fig.  1). Arm antibody (A 
and  B)  recognizes  a  large  class  of high  molecular  weight 
fragments and after double-column treatment (B) the reactiv- 
ity to stub (B, lane 3) is almost entirely removed. The intensity 
of staining of arm fragments (lane 2) and intact MAP (lane 
I) remains about the same. 
It can be seen that stub antibody (C and D) binds strongly 
to the 35-40-kD stub (lane 3) and to intact MAP (lane 1) but 
also binds to high molecular weight cleavage products present 
FIGURE  1  Immunoblot  demonstrating  reactivities  of  rabbit  anti- 
bodies against  intact MAP-2, arm,  and stub antigens.  The affinity 
purification of arm- and stub-specific antibodies by single-column 
and double-column purification methods is described in Materials 
and Methods. In each panel, lane 1 contains intact MAP-2, lane 2 
contains arm  antigen,  and lane 3 contains stub antigen. (A and B) 
Arm antibody after single-column (A) and double-column purifica- 
tion (B). (C and D) Stub antibody after single-column (C) and double- 
column purification (D). 
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in the arm fraction (lane 2).  The reactivity to fragments in 
the  arm  fraction  probably represents the  presence  of high 
molecular weight  fragments that  contain  part  of the  stub 
region.  Such  fragments could be produced if chymotrypsin 
cleaved dissociated MAPs  at secondary sites.  Although  the 
stub  and  arm  antibodies  showed  a  certain  degree  of non- 
specificity by immunoblotting,  in  practice, both antibodies 
proved to  be highly  specific for morphologic analyses and 
studies of microtubule assembly (see Discussion). 
Since the stub antigen used in preparing the affinity column 
was SDS denatured, we first determined if the antibody from 
this column was able to recognize native (nondena~red) stub. 
Native stub was obtained by the methods of Vallee and Borisy 
(1977),  and Vallee ( 1982): microtubules treated with alpha- 
chymotrypsin were pelleted and stubs released from the taxol- 
stabilized microtubules by resuspension in buffer containing 
high salt were isolated from the supernate following a second 
centrifugation to remove microtubules. A  side-by-side com- 
parison  of native stub and  intact  MAP-2  by a  solid-phase 
binding assay confirmed that the stub antibody was capable 
of recognizing native stub as well as intact MAP-2 (data not 
shown). 
Antibody Decoration of Intact Microtubules 
Glutaraldehyde-fixed microtubules were labeled with stub 
antibody,  arm antibody,  or whole  (unfractionated)  MAP-2 
antibody, followed by decoration with protein A-gold, and 
negatively stained for examination by electron microscopy. 
Microtubules were densely and uniformly labeled with tubulin 
antibody (Fig.  2D),  but  were not  labeled with  preimmune 
IgG (Fig.  2E),  indicating that  microtubules are  specifically 
labeled  by this  procedure.  Microtubules  containing  MAPs 
were also heavily labeled after incubation with unfractionated 
MAP antibody (Fig. 2A) or with arm antibody (Fig. 2B). The 
presence of IgG-protein A-gold complexes away from the 
microtubule wall is consistent with the finding that MAP-2 
projects away from microtubule surfaces (compare with the 
pattern of labeling with tubulin antibody in Fig.  2D). Incu- 
bation  with  stub  antibody,  however,  gave  minimal  or  no 
labeling, (Fig.  2 C),  suggesting that the stub region may not 
be accessible to antibody while bound to microtubules. 
Antibody Labeling of Microtubules Digested 
with Chymotrypsin 
Microtubules digested with chymotrypsin (0.1 t~g/mg MTP) 
sufficient to remove arms (electron microscopic analysis) and 
cleave >90%  of the  MAP-2 band (gel analysis) can still  be 
labeled with MAP antibody (Fig. 3 B). In an earlier report we 
concluded that the labeling obtained after digestion with 0.1 
ug chymotrypsin may be due to the binding of MAP antibody 
by the remaining MAP stubs (Gottlieb and Murphy,  1983). 
However, the finding described in the previous section, that 
stub antibody does not bind to microtubules, prompted us to 
examine the disposition of the stub on microtubule surfaces 
in  more  detail.  To  achieve a  more complete digestion  we 
therefore  used  a  higher  enzyme concentration  (0.2  vg/mg 
MTP). Coomassie Blue-stained gels of microtubules treated 
in this way indicated loss of intact MAP-2, the presence of 
35-40-kD  stub,  and  varying quantities  of high  molecular 
weight fragments (data not shown). These microtubules could 
no longer be labeled with any of the MAP antibody fractions FIGURE 2  Electron  micrographs  of microtubules labeled with rabbit polyclonal antibodies and protein A-gold, and negatively 
stained with uranyl acetate.  (A) Microtubules labeled with affinity-purified MAP-2 antibody (but not fractionated into arm and 
stub fractions)  are heavily labeled. (B) Microtubules incubated with arm antibody are also extensively decorated. (C) Labeling 
microtubules with stub antibody causes little or no decoration. (D) Tubulin antibody gives dense, uniform labeling. (E) Preimmune 
IgG from the rabbit from which MAP-2 antibodies were obtained does not label microtubules, xi04,000. 
(Fig. 3 C). This result is consistent with the lack of decoration 
seen with stub antibody (Fig.  2 C) and suggests that the 35- 
40-kD stub portion of MAP-2  is not accessible to antibody 
while bound to microtubules. 
Stub Antibody Inhibits Microtubule Assembly 
To  prove  that  the  stub  antibody  in  fact  bound  to  the 
microtubule-binding  domain  of MAP-2,  we  examined  the 
effects of MAP antibodies on microtubule assembly. Table I 
shows the inhibition we observed when antibodies were prein- 
cubated  with  soluble  microtubule  protein  at  0*C  prior  to 
elongation on microtubule seeds. The details of  the procedure 
are described in Materials and Methods.  The results of two 
series of experiments, designated series A and B, are shown. 
The addition of preimmune IgG at 0.05 mg/ml (A) had little 
effect on polymerization, although it was somewhat inhibitory 
at 0.5  mg/ml (B).  This was true generally for IgG fractions 
prepared  from  rabbit  serum.  MAP  antibody  resulted  in  a 
reduced amount of polymerization in series A but gave rise 
to increased turbidity in  series B; however, electron micro- 
scopic inspection of this sample revealed cross-linked micro- 
tubules and immune complexes, not seen in the other sam- 
ples. Arm antibody had an effect not much greater than that 
of preimmune serum. In both series, stub antibody was effec- 
tive in partially inhibiting polymerization. This presumably 
is due to the fact that stub antibody specifically binds to the 
microtubule-binding portion of MAP-2 and thereby prevents 
its association with microtubules. It is curious that the rate of 
elongation was not inhibited to an even greater extent, but it 
is possible that microtubule elongation is effectively stimu- 
lated by even small amounts of MAPs. 
We found that microtubule self-assembly was not inhibited 
by stub antibody when antibody was added to depolymerized 
microtubule protein containing ring oligomers before polym- 
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Percent inhibition* 
Preim-  MAP anti-  Arm anti-  Stub anti- 
Experiment  mune IgG  body  body  body 
A  0  23  --  40 
B  0  <0'  11  41 
In experiment A, the MAP:antibody molar ratio was 10:1. In experiment B 
the ratio was 1:1. In both series, 700-~1 aliquots of high-speed  supernate  of 
microtubule  protein at  1 mg/ml were incubated with antibody on  ice  for 
15 rain.  Samples were placed  in a cuvette, allowed to equilibrate to 30"C 
for 45 s, then seeds (25 t~l of cycled, polymerized microtubules at 5 mg/ml) 
were added to the sample  in  the cuvette. Changes  in  the turbidity were 
followed at 350 nm and rates of polymerization were determined from the 
initial  slope according 1o the methods of Murphy et al. (1977). 
*The  values  represent  percent  inhibition  relative to  the  preimmune  IgG 
control  which  is  designated  0%  inhibition.  In  fact, the  presence  of IgG 
slightly  inhibits  elongation, the amounts observed  relative to PBS controls 
,being 2% for series A and 33% for series B. 
Increased  turbidity  and  electron  microscopic  inspection  of  the  sample 
indicated immune complexes containing cross-linked  microtubules. 
FIGURE  3  Electron  micrographs of microtubules treated with al- 
pha-chymotrypsin before labeling with MAP-2 antibody and protein 
A-gold. Taxol-stabilized microtubules were treated with enzyme 
for  15  rain,  arrested with  5  mM  phenylmethylsulfonyl fluoride, 
pelleted through  sucrose,  resuspended  in  assembly  buffer  with 
glutaraldehyde, and  prepared for immunoelectron microscopy as 
described in Materials and Methods. Microtubules shown in A were 
not treated with enzyme. In B, microtubules were treated with 0.1 
#g alpha-chymotrypsin/mg  MTP as described in Materials  and Meth- 
ods. In C, microtubules were treated with 0.2 #g enzyme/mg MTP. 
x 104,000. 
erization at 30"C.  Stub antibody also did not depolymerize 
pre-assembled microtubules over time intervals  of 5  to  60 
min.  These  observations indicated  that  the  stub  region  of 
MAP-2 must be accessible in order to observe antibody inhi- 
bition of assembly. 
Comparisons of the Chymotryptic Cleavage 
Patterns of MAPs On and Off Microtubules 
If  the stub region was inaccessible to antibody while bound 
to microtubules, we reasoned that it might also show differ- 
ential sensitivity to proteolytic enzymes such as alpha-chy- 
motrypsin, depending on whether it was bound to microtu- 
bules or free in  solution.  To investigate this possibility, we 
compared the rates of appearance of the stub peptides in two 
samples of taxol-stabilized microtubules, one of which con- 
tained 0.3 M  NaC1 to release MAPs from the microtubules. 
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Aliquots  of both  samples were  removed  after addition  of 
chymotrypsin and examined by immunoblotting using MAP 
antibody and  ~25I-protein A  to specifically visualize the  36- 
and 40-kD stub peptides of MAP-2.  In control experiments 
we determined  that the  MAPs  in  this sample were free in 
solution and fully accessible to enzyme and that the rate and 
extent of digestion  of purified  MAPs  free in  solution  were 
identical with or without the addition  of salt.  In particular, 
the presence of salt did not alter the rates of appearance and 
disappearance of the 36- and 40-kD peptides in preparations 
of purified MAP-2. 
In the presence of microtubules, however, differences were 
observed in the MAP digestion patterns with respect to the 
stub peptides. In mierotubule preparations containing MAPs, 
both the 36- and 40-kD fragments were generated rapidly but 
the 36-kD fragment eventually disappeared while the amounts 
of the 40-kD fragment remained nearly unchanged for at least 
30  min  (Fig.  4A).  In  preparations  containing  dissociated 
MAPs, the 40-kD fragment appeared first and was the pre- 
dominant  fragment as the  amounts of the  36-kD  fragment 
gradually increased.  After -10  min,  both  species began  to 
decline with the 40-kD species disappearing completely by 30 
min  (Fig.  4B).  These observations reveal significant differ- 
ences  in  the  extent  and  time  of appearance  of the  stub 
peptides, depending on their state of association with micro- 
tubules. In particular, the 40-kD stub peptide appears to be 
relatively stable to digestion when MAPs are associated with 
microtubules, suggesting that the cleavage sites responsible for 
generating this fragment are closely associated with,  or par- 
tially buried in, the microtubule surface. 
Platinum Shadowing of MAP-2 Stub 
Antibody Complexes 
To  determine  the  location  and  size  of the  microtubule- 
binding  domain  of  MAP-2,  we  incubated  intact  purified 
MAP-2  in  solution  with  stub  antibody  and  visualized  the 
antigen-antibody complexes by platinum shadowing. We ob- 
served thin, extended molecules similar to those described by 
Voter  and  Erickson  (1982),  but  dissimilar to  the  globular 
particles described by Zingsheim et at. (1979).  Shown in Fig. 
5 are representative MAPs with associated stub antibody. The 
mean length and maximum length of isolated MAPs were 90 A,_,  ~  '  'o 
%  . 
I  ! 
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FIGURE  4  Differential  chymotryptic  cleavage  of  MAP-2  while 
bound to microtubules or free in solution. Microtubules stabilized 
in 10/zM taxol and containing MAPs were digested for various times 
with  alpha-chymotrypsin (0.1 /~g  chymotrypsin/mg MTP,  37°C). 
Cleavage  products derived from MAP-2  were visualized by immu- 
noblotting using an antibody specific for MAP-2  and '2Sl-protein A. 
The figure shows the amount of the 36-kD (O) and 40-kD (O) stub 
peptides as  determined  by  densitometry of  the  autoradiogram. 
Electron  microscopic examination confirmed that the microtubules 
persist throughout the digestion period. (A) Digestion of microtu- 
bules with associated  MAPs  in  assembly buffer.  (B)  Digestion of 
microtubules in  assembly buffer with 0.3  M  KCl to release MAPs 
from microtubule surfaces. 
___ 30 nm and  125  nm, respectively, but in one or two cases 
MAPs  170 nm long were observed (Fig.  6). These values are 
somewhat shorter than the value of 185 nm reported by Voter 
and Erickson (1982).  The large variability in length (SD =  30 
nm) suggests that the conformation of isolated MAPs may be 
variable; although gel electrophoresis showed that some pro- 
teolysis of MAP-2 had occurred, the extent of proteolysis is 
probably too minor to account for the variability in the lengths 
we observed. The width of MAP-2 is probably less than the 
actual  measured  value of 40  nm,  since the  isolated  MAPs 
could  only be detected  after unidirectional  shadowing at a 
low angle (6*) and completely disappeared after rotary shad- 
owing. 
In  surveying the  platinum-shadowed  samples,  both  free 
MAPs  and  MAP-antibody  complexes could  be  found.  As 
shown in Fig.  7,  the  striking feature was that >90%  of the 
complexes had antibody bound near one end and within one- 
quarter of the extended MAP-2 molecule; the remaining 10% 
had antibody attached in the middle one-third of the protein. 
However, in these cases the  MAPs were found to be much 
longer than the average length, suggesting that the bifunctional 
antibody had bound two MAPs end-to-end. In no case was 
antibody observed bound  to  both ends of the  molecule.  If 
these unusual complexes are eliminated, we conclude that the 
microtubule-binding domain is located at just one end of the 
molecule.  We  estimate  that  the  position  of the  35-40-kD 
region recognized by stub antibody is located within 40 nm 
of one  end  of the  MAP  terminus.  The  stub  domain  may 
therefore comprise up to  one-third  of the  length  of an ex- 
tended molecule with a length of 125 nm. 
FIGURE  5  Platinum shadowing of isolated MAP-2 after incubation 
with  MAP  stub antibody. MAPs  were  incubated with  equimolar 
amounts of stub antibody and diluted in 20% glycerol as described 
in Materials and Methods, sprayed onto mica with an atomizer, and 
unidirectionally shadowed with  platinum at an  angle of 6*.  The 
antibody is located at one end of the extended MAP molecule. The 
top row shows MAP molecules that are not labeled with antibody. 
Bar, 100 nm. x130,000. 
DISCUSSION 
MAP-2 Contains a Single Antigenic Determinant 
to the Microtubule-binding Domain 
Using affinity chromatography, we subfractionated rabbit 
antibodies to whole MAP-2 into two fractions that are specific 
for the respective "stub" and "arm" domains of the molecule. 
Stub  antibody  is  quite  specific  after  passage  over an  arm 
column  and its  specificity is not  significantly improved by 
double-column treatment (arm column followed by stub col- 
umn). The fact that stub antibody also labels high molecular 
weight  fragments  suggests  that  large  immunoreactive  frag- 
ments containing the stub region are also generated by the 
chymotryptic cleavage procedure. This is consistent with the 
observations  of Scherson  et  al.  (1982),  who  described  an 
alternative cleavage pathway in which chymotrypsin cleaves 
the stub region and much of the projecting portion of MAP- 
2 and suggests that a certain percentage of MAPs are free in 
solution. We do not feel that the binding of stub antibody to 
high molecular weight peptides represents common antigenic 
determinants between stub and arm, because double-column 
purification would eliminate all cross-reactivity, rather than 
give rise  to  the  results we  observe, i.e.,  no  change  in  the 
labeling pattern by stub antibody and a significant reduction 
in  labeling  of the  35--40-kD  stub  by  arm  antibody.  Our 
observations of platinum shadowing of stub antibody-MAP- 
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FIGURE  6  Length  distribution  of  MAP-2.  Measurements  were 
made  from  enlarged  photographs  of  platinum-shadowed MAP- 
antibody complexes (n =  93). The mean length was 90 +  30 nm. 
The maximum length observed was 170 nm. 
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FIGURE  7  Determination of the size and position of the stub region 
on isolated MAP molecules. The measurements indicate the space 
between the antibody and the nearest end of the molecule. Mea- 
surements were made from photographic enlargements to nearest 
whole millimeter, where the average maximum MAP length was 16 
mm (125 nm).  Stub antibody bound most frequently at a position 
ranging from 0 to 40 nm from one end of the molecule. 
2  complexes also  argue  against  the  possibility  of multiple 
antigenic determinants within the molecule, since we consis- 
tently  observed  antibody  binding  to  only  one  end  of the 
molecule. 
The Microtubule-binding  Domain May Become 
Hidden When MAPs  Are Associated 
with Microtubules 
The stub antibody we prepared did not label microtubules 
and  was  therefore  not  useful  for  examining  the  periodic 
distribution of MAP-2 on microtubules. It is possible that the 
antigenic sites on the stub are inaccessible  to antibody when 
associated  with the microtubule wall, which could happen if 
the stub region of MAP-2 were located in a groove between 
adjacent tubulin subunits, wide enough to accommodate the 
thin MAP filament (reported by Voter and Erickson [1982] 
to be >1.5 nm), but inaccessible  to antibodies.  Similarly,  our 
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analysis  of the  chymotryptic digestion  products  of MAP-2 
indicated differential  cleavage at sites resulting in the 36- and 
40-kD stub peptides,  with the 40-kD peptide being generated 
more rapidly for dissociated  MAPs and being relatively more 
stable for microtubule-associated MAPs. Thus chymotrypsin 
may also have limited access to MAPs bound to the micro- 
tubule wall. That the stub region is inaccessible  to antibody 
while bound to microtubules is also supported by our obser- 
vations on the effects of stub antibody on microtubule assem- 
bly and stability  (see below).  An alternate idea that has not 
yet been ruled out is that the MAP stub remains exposed and 
that the antigenic sites are hidden or undergo conformational 
changes upon microtubule binding, but we do not consider 
these  likely,  given the consistency of antibody and chymo- 
trypsin experiments and the polyclonal nature of the rabbit 
antibody to stub. 
MAP Stub Antibody Inhibits 
Microtubule Assembly 
Incubation of MAP or stub antibody with ring-free micro- 
tubule  protein  interferes  with  subsequent  elongation  onto 
added seeds. To observe the effect it was necessary  to prein- 
cubate  the  antibody with  ring-free  preparations  of soluble 
microtubule protein  at  5"C prior to assembly at  30"C. We 
were unable to induce depolymerization of assembled  micro- 
tubules,  presumably because the region of MAP-2 necessary 
for microtubule stabilization  is inaccessible  to antibody. We 
also found that the presence of rings prevented the inhibitory 
effects of  stub antibody on microtubule elongation, suggesting 
that the stub region of MAP-2 is also  protected in tubulin 
ring  oligomers,  and  we  conclude that  during  microtubule 
elongation, the stub region may be accessible for only a brief 
time or not at all. Although our own preliminary evidence 
suggests that MAPs exchange on and off  microtubules, so that 
they should be accessible to stub antibody at least some of the 
time, MAP antibody did not promote the disassembly  of pre- 
formed  microtubules;  however,  we  were  restricted  to  low 
concentrations of antibody, and this  may have limited our 
ability to see an effect. 
The manner in which MAPs stabilize microtubules and the 
role they  may play  in  nucleation,  formation of rings,  and 
assembly of  microtubules are not well understood, and further 
work is needed.  However, these studies  provide preliminary 
evidence that a  portion of the  microtubule binding site  of 
MAP-2 may be hidden when MAPs. are bound to microtu- 
boles or to tubulin oligomers.  Since  different  regions of the 
MAP-2 molecule may be involved in different functions, the 
use of stub and arm antibodies may provide new information 
about the way in which MAPs interact with tubulin and other 
cytoskeletal  components. 
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